The Alcoholic Hepatitis Network project, AlcHepNet, comprised of ten leading partner institutions in the field, will collect and organize patient information, associated data, and samples that can help shed greater light on this disease. Combined, these approaches will improve treatment and how we care for patients with this devastating liver condition.
Alcoholic hepatitis (AH) is a leading cause of liver-related morbidity and mortality. This network represents a coordinated submission of several NIAAA-funded consortia that have come together as the Alcoholic Hepatitis Network (AlcHepNet). Collectively, the network will synergize efforts and expertise to better understand AH. The network aims to:
- To collect and store clinical data to facilitate investigations of the epidemiology, diagnosis, pathophysiology, natural history, and treatment of alcoholic hepatitis.
- To develop a bio-specimen bank comprised of plasma, DNA, and other biological specimens obtained from patients with alcoholic hepatitis, heavy drinkers without clinical liver disease.
AlcHepNet is a clinical and translational research initiative funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a division of NIH.